TLDR The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.
The retrospective, case-series study involved 9 female patients with androgenetic alopecia (FAGA) and evaluated the efficacy of a treatment combining autologous platelet-rich plasma (PRP) and a non-cross-linked hyaluronic acid (HA) compound. The treatment led to a significant improvement in hair density and reduction in areas of alopecia, with a 54.51% increase in hair count at 1 month and a 77.25% increase at 3 months. The treatment's clinical efficacy could last beyond 3 months, and patients reported high satisfaction levels. Mild side effects occurred but resolved within 72 hours, and no serious adverse events occurred, indicating the treatment is safe and well-tolerated. The study concluded that the combination of PRP and non-cross-linked HA compound is effective and safe in treating FAGA, but further randomized controlled trials with larger sample sizes are needed to confirm these findings.View this study on onlinelibrary.wiley.com →
PRP improves hair thickness for both genders, but only increases hair density in men.
PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.
PRP therapy improves hair density and thickness in AGA patients, even with other treatments.
Male pattern baldness involves genetics, hormones, and needs better treatments.
PRP treatment may stimulate hair growth by promoting blood vessel formation, increasing growth factors, and preventing cell death.
Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.
Platelet-rich plasma can potentially promote hair growth by stimulating cell growth and increasing certain proteins.
Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.
Spironolactone helps regrow hair in women with hair loss.
Finasteride works better for hair loss in patients 26 or younger.
Androgenetic alopecia in women needs more research and better management strategies.
Hair loss in women is common, starts in late 20s, and affects 30% of women over 50.
The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.
Platelet-rich plasma injections can effectively treat male pattern hair loss, improving hair density and quality with high patient satisfaction.